BioAge Labs (BIOA) Q2 2026 earnings — TrendMatrix coverage
BEAT · SMALLER LOSS+7.1% vs estimateEPS -$0.58 vs -$0.62 est
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Event detail · Q2 2026
Key numbers
- Adjusted EPS
- -$0.58
- Estimate
- -$0.62
- Surprise
- +7.1%
- Revenue (period 2026-06-30)
- $2.5M
Revenue source: xbrl.
Report record · Q2 2026
How the report landed
BioAge Labs (BIOA) reported a narrower loss than forecast — adjusted EPS of -$0.58 against the -$0.62 estimate (a 7.1% beat on a still-unprofitable quarter).